Butyrate as a promising therapeutic target in cancer: From pathogenesis to clinic (Review).
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5632
- By:
- Publication type:
- Article
Works matching IS 10196439 AND DT 2024 AND VI 64 AND IP 4
Results: 12
1
2
Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis.
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5633
- By:
- Publication type:
- Article
3
Characterization of KIF20B as a novel prognostic biomarker and therapeutic target for breast cancer.
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5631
- By:
- Publication type:
- Article
4
Targeting mitochondrial bioenergetics by combination treatment with imatinib and dichloroacetate in human erythroleukemic K-562 and colorectal HCT-116 cancer cells.
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5630
- By:
- Publication type:
- Article
5
Xenograft and organoid models in developing precision medicine for gastric cancer (Review).
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5629
- By:
- Publication type:
- Article
6
Chimeric antigen receptor T cells in the treatment of osteosarcoma (Review).
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5628
- By:
- Publication type:
- Article
7
Advancements in colorectal cancer research: Unveiling the cellular and molecular mechanisms of neddylation (Review).
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5627
- By:
- Publication type:
- Article
8
A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review).
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5626
- By:
- Publication type:
- Article
9
Cucurbitacin IIa promotes the immunogenic cell death-inducing effect of doxorubicin and modulates immune microenvironment in liver cancer.
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5625
- By:
- Publication type:
- Article
10
HER2<sup>+</sup> advanced gastric cancer: Current state and opportunities (Review).
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5624
- By:
- Publication type:
- Article
11
Immunotherapy targeting PD‑1/PD‑L1: A potential approach for the treatment of cancer bone metastases (Review).
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5623
- By:
- Publication type:
- Article
12
GBP2 enhances paclitaxel sensitivity in triple-negative breast cancer by promoting autophagy in combination with ATG2 and inhibiting the PI3K/AKT/mTOR pathway.
- Published in:
- International Journal of Oncology, 2024, v. 64, n. 4, p. N.PAG, doi. 10.3892/ijo.2024.5622
- By:
- Publication type:
- Article